Abstract: The present invention relates to an improved process for the preparation of zileuton represented by the structural formula-1.
Field of the Invention:
The present invention relates to an improved process for the preparation of zileuton. Zileuton is chemically knovm as (±)-N-hydroxy-N-(l-benzo-[b]thien-2-ylethyl) urea and is represented by structural formula-1.
Zileuton is a potent leukotriene biosynthesis inhibitor. Leukotrienes have been implicated as important mediators of asthma, allergy, arthritis, psoriasis, and inflammation, and Zileuton which is an inhibitor of biosynthesis of leukotrienes offers treatment for leukotriene given mediated afflictions in man. Zileuton is commercially available under the brand name of "zyflo" and supplied as a tablet with different strengths.
Background of the Invention:
N-benzo[b]thienyl-N-hydroxyureas, as exemplified by N-(l-benzo[b]thien-2-ylethyl)-N-hydroxyurea (zileuton, U.S. Pat. No. 4,873,259) are potent leukotriene biosynthesis inhibitors. However, N-benzo[b]thienyl-N-hydroxyurea is difficult to prepare with required purity and yield, especially has proven to be a synthetic challenge commercially.
The synthesis of zileuton offers several illustrations of typical methods to prepare benzo[b]thienyl substituted N-hydroxyureas. In U.S. Pat. No. 4,873,259 a process is illustrated which involves reacting 2-acetylbenzo[b]thiophene with hydroxylamine to form the corresponding oxime. Then the oxime is reduced with an excess of reducing agent, generally borane-pyridine complex, to form l-benzo[b]thien-2-ylethyl hydroxylamine. Finally, the hydroxylamine is reacted with trimethylsilyl isocyanate or sodium or potassium cyanate to form the corresponding N-hydroxyurea. Due to the safety considerations and cost involved several alternative preparations of N-(l-benzo[b]thien-2-ylethyl)-N-hydroxyureas have been devised.
One alternative process given in U.S. Pat. No. 4,873,259 involves reacting (l-benzo[b]thien-2-yl)-l-chloroethane with a nitrogen nucleophile. The nitrogen moiety is then converted to the N-hydroxyurea. However, direct displacement of chloride with hydroxylamine gives a mixture of N- and 0-alkylation. Therefore, an 0-protected hydroxylamine derivative such as 0-benzylhydroxylamine is used as the nitrogen nucleophile. Then the product of the displacement reaction is deprotected to give 1-benzo[b]thien-2-ylethyl hydroxylamine. The hydroxylamine is then converted to the N-hydroxyurea as described above. The displacement has also been accomplished using Z-furfuraldehyde oxime and base to give the nitrone, which is hydrolyzed with acid or reacted with hydroxylamine to give l-benzo[b]thien-2-ylethyl hydroxylamine. Other O-protected nitrogen nucleophiles such as 0-protected hydroxyurea derivatives, for example 0-(tetrahydropyran-2-yl)-N-hydroxyurea, have also been used to displace chloride. Removal of the oxygen protecting group provides the N-hydroxyurea.
One process cited by A.O. Stewart and D. W. Brooks, in J. Org. Chem., 57 (18), 5020(1992) circumvents the conversion of the (l-benzo[b]thien-2-yl)-l-hydroxyethane to the corresponding chloride by using the Mitsunobu coupling. In this process (1-benzo[b]thien-2-yl)-l-hydroxyethane is reacted with N,0-bis(phenoxycarbonyl)hydroxyl amine, followed by aminolysis to obtain Zileuton. Mitsunobu reaction involves the use of diisopropyl azadicarboxylate which is highly toxic and hence not recommended for large scale production.
The processes described above require either many synthetic steps, and/or protection and deprotection of the hydroxylamine which is expensive and inefficient on a large scale. The pharmaceutical manufacturing industry still seeks a N-substituted-N-hydroxyurea synthesis that can be accomplished in a few steps with a minimum amount of expensive reducing agents or protecting groups.
The present invention provides a improved process for the preparation of zileuton which avoids all the above mentioned prior art problems
Brief Description of the Invention:
The first aspect of the present invention is to provide an improved process for the preparation of zileuton, compound of formula-1, which comprises of the following steps,
a) Treating l-(benzo[b]thiophen-2-yl)ethanone compound of formula-2 with sodium borohydride to provide l-(benzo[b]thiophen-2-yl)ethanol, compound of formula-3,
b) reacting the compound of formula-3, with N-hydroxy carbamate, compound of general formuIa-4, in a suitable solvent in the presence of acid to provide 1-(benzo[b]thiophen-2-yl)ethyl(hydroxy)carbamate, compound of general formula-5,
c) treating compound of formula-5 with ammonia to provide zileuton, compound of formula-1.
The second aspect of the present invention is to provide an improved process for the preparation of zileuton, compound of formula-1, which comprises of the following steps,
a) reacting the compound of formula-3, with N-hydroxy carbamate, compound of general formuIa-4, in a suitable solvent in the presence of acid to provide 1-(benzo[b]thiophen-2-yl)ethyl(hydroxy)carbamate, compound of general formula-5,
b) treating compound of formula-5 with ammonia source to provide zileuton, compound of formula-1.
The third aspect of the present invention is to provide a improved process for the preparation of zileuton, compound of formula-1, which comprises of reacting the l-(benzo[b]thiophen-2-yl)ethanol, compound of formula-3, with N-hydroxyurea in a suitable solvent in the presence of dehydrating agent like zinc chloride to provide zileuton compound of formula-1.
The fourth aspect of the invention is to provide an improved process for the preparation of zileuton, compound of formula-1, which comprises of the following steps, a) Reacting l-(benzo[b]thiophen-2-yl)ethanone compound of formula-2 with
hydroxylamine to provide l-(benzo[b]thiophen-2-yl)ethanone oxime compound of
formula-7.
b) reducing the compound of formula-7 using borane-pyridine complex to provide N-(l-(benzo[b]thiophen-2-yl)ethyl)hydroxylamine compound of formula-8,
c) reacting the compound of formula-8, with urea in presence/absence of a suitable solvent to provide zileuton, compound of formula-1.
Advantages of the Present Invention:
• Provides an improved process for the preparation of Zileuton
• Provides a process with better yields and high purity of the intermediates, as well as zilueton.
• Avoids the use of toxic reagents like diisopropyl azadicarboxylate, sodium or potassium cyanate, triphosgene etc.
• Eco-firiendly and cost effective process.
Brief Description of the Drawings:
Figure-1: Illustrates the powder X-ray diffraction pattern of crystalline Zileuton
Figure-2: Illustrates the IR spectrum of crystalline Zileuton
Figure-3: Illustrates the powder DSC thermogram of crystalline Zileuton
Figure-4: Illustrates the Zileuton mor{)hology as seen through microscope.
Detailed description of the invention:
Unless otherwise indicated, this disclosure uses definitions provided below. As used herein, the term "alkyl" refers to straight chain or branched hydrocarbon groups, generally having specified number of carbon atoms. A "Ci-12 alkyl" refers to alkyl group having 1 to 12 carbon atoms. Examples of alkyl groups include, without limitation, methyl, ethyl, n-propyl, iso-propyl, n-butyl, sec-butyl, iso-butyl, t-butyl, pent-1-yl, pent-2-yl, pent-3-yl, 3-methylbut-l-yl, 3-methylbut-2-yl,2-methylbut-2-yl, 2,2,2-trimethyleth-1-yl, n-hexyl and the like.
As used herein, the term "cycloalkyl" refers to saturated monocyclic and bicyclic hydrocarbon rings, generally having a specified number of carbon atoms that comprise the ring i.e C3.7 cycloalkyl refers to a cycloalkyl group having 3,4,5,6and 7 carbon atoms as ring members. Examples of monocyclic groups include, without limitation.
cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, and the like. Examples of bicyclic cycloalkyl groups include without limitation, bicyclo[1.1.0]butyl, bicyclo[l.l.l]pentyl, bicyclo[2.1.0]pentyl, bicyclo[2.1.1]hexyl, bicyclo[2.2.0]hexyl, bicyclo[3.1.0]hexyl, bicyclo[2.2.1]heptyl, bicyclo[3.2.0]heptyl and the like.
As used herein, the term "aryl-Ci.6 alkyl" refers to an aryl group attached to the substrate through an alkyl group containing one to six carbon atoms. The term "aryl" refers to monovalent or divalent Jiromatic groups respectively including 5 and 6 membered monocyclic aromatic groups that contain zero to four heteroatom independently selected from nitrogen, oxygen and sulfur. Examples of monocyclic aryl groups include, without limitation, phenyl, pyrrolyl, pyranyl, furanyl, thiophenyl, thiazolyl, isothiazolyl, imidazolyl, triazolyl, tetrazolyl, pyrazolyl, oxazolyl, isoxazolyl, pyridinyl, pyrazinyl, pyradazinyl, pyrimidinyl, and the like. The aryl groups also include bicyclic groups, tricyclic groups etc including fused 5 and 6 membered rings described above. Examples of multicyclic aryl groups include, without limitation, naphthyl, biphenyl, anthracenyl, pyrenyl, carbazolyl, benzoxazolyl, benzodioxazolyl, benzothiazolyl, benzoimidazolyl, benzothiophenyl, quinolinyl, isoquinolinyl. indolyl, benzofuranyl, purinyl, indolizinyl and the like. The aryl groups may be attached to the substrate at any ring atom, unless such attachment would violate valence requirements.
Aryl groups may include one or more non hydrogen substituents unless such substitution would violate valence requirements. Useful substituents include, without limitation alkyl, alkenyl, alkynyl, haloalkyl, alkoxy, halo, hydroxy, mercapto, nitro, amino, alkyl amino and the like.
The first aspect of the present invention provides an improved process for the preparation of zileuton, compound of formula-1, which comprises of the following steps, a) Treating l-(benzo[b]thiophen-2-yl)ethanone compound of formula-2
OK.
Formula-2
with sodium borohydride in alcohol solvent, to provide l-(benzo[b]thiophen-2-yl) ethanol, compound of formula-3,
Formula-S
b) reacting the compound of formula-3, with N-hydroxy carbamate, compound of
general formula-4,
H Formula-4 wherein R is a Ci.i2alkyl,C3.7cycloalkyl, aryl or aryl-Ci-e alkyl, in a suitable solvent in the presence of acid to provide l-(benzo[b]thiophen-2-yl) ethyl(hydroxy)carbamate, compound of general formula-5,
HO OR
Formula-5 wherein R is a Ci.12 alkyl,C3.7cycloalkyl, aryl or aryl-Ci.6 alkyl,
c) treating compound of formula-5 with ammonia source to provide zileuton, compound
of formula-1.
In the step a) the reduction of l-(benzo[b]thiophen-2-yl)ethanone compound of formula-2 with sodium borohydride is carried out in a alcohol solvent selected from methanol, ethanol, isopropanol, n-propanol, n-butanol, isobutanol, preferably methanol.
In the step b) the condensation of l-(benzo[b]thiophen-2-yl)ethanol, compound of formula-3, with N-hydroxy carbamate, compound of general formula-4, is carried out in non polar aprotic solvent which includes but not limited to benzene, toluene, xylene, tetrahydofuran, 2-methyltetrahydrofuran, preferably toluene. The acid used is selected from an inorganic acid or organic acid. The inorganic acid is selected from a group consisting of but not limited to hydrochloric acid, hydrobromic acid, sulfuric acid, nitric
acid, phosphoric acid and the like or lewis acids like aluminium chloride, aluminium bromide, ferric chloride, boron trifluoride, boron trichloride, stannous chloride, titanium tetrachloride and the like. The organic acid is selected from a group consisting of but not limited to acetic acid, trifluoroacetic acid, ethanoic acid, propionic acid, paratoluene sulfonic acid and the like.
In the step c) the source for ammonia includes ammonia gas, ammonium hydroxide, ammonium acetate, ammonium chloride, ammonium carbonate, and the like. The suitable solvent that can be used include, without limitation, aromatic hydrocarbon solvents like toluene, xylene; halogenated solvents such as dichloromethane, chloroform, 1,2-dichloroethane and the like; alcoholic solvent like methanol, ethanol, isopropanol, n-propanol, n-butanol, isobutanol; keto solvents like acetone, methyl ethyl ketone, diethyl ketone; ester solvents like ethyl acetate, propyl acetate and acetonitile.
The second aspect of the present invention provides an improved process for the preparation of zileuton, compound of formula-1, which comprises of the following steps, a) Reacting the compound of formulai-3,
OK.
Formula-3 with N-hydroxy carbamate, compound of general formula-4,
H Formula-4 wherein R is a Cun alkyl, C3.7 cycloalkyl, aryl or aryl-Ci^ alkyl, in a suitable solvent in the presence of acid to provide l-(benzo[b]thiophen-2-yl) ethyl(hydroxy)carbamate, compound of general formula-5,
HO OR
o
-S 'CH3 Formula-5
cm:''
wherein R is a C1.12 alkyl, C3-7 cycloalkyl, aryl or aryl-Ci.6 alkyl, b) treating compound of formula-5 v/ith ammonia source to provide zileuton, compound of formula-1.
In the step a) the condensation of l-(benzo[b]thiophen-2-yl)ethanol, compound of formula-3, with N-hydroxy carbamate, compound of general formula-4, is carried out in non polar aprotic solvent which includes but not limited to benzene, toluene, xylene, tetrahydofuran, 2-methyltetrahydrofliran, preferably toluene. The acid used is selected from an inorganic acid or organic acid. The inorganic acid is selected from a group consisting of but not limited to hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid and the like or lewis acids like aluminium chloride, aluminium bromide, ferric chloride, boron trifluoride, boron trichloride, stannous chloride, titanium tetrachloride and the like. The organic acid is selected from a group consisting of but not limited to acetic acid, trifluoroacetic acid, ethanoic acid, propionic acid, paratoluene sulfonic acid and the like.
In the step b) the source for ammonia includes ammonia gas, ammonium hydroxide, ammonium acetate, ammonium chloride, ammonium carbonate, and the like. The suitable solvent that can be used include, without limitation, aromatic hydrocarbon solvents like toluene, xylene; halogenated solvents such as dichloromethane, chloroform, 1,2-dichloroethane and the like; alcoholic solvent like methanol, ethanol, isopropanol, n-propanol, n-butanol, isobutanol; keto solvents like acetone, methyl ethyl ketone, diethyl ketone; ester solvents like ethyl acetate, propyl acetate and acetonitile.
The N-hydroxy carbamate, compounds of general formula-4 are prepared by treating hydroxylamine hydrochloride with the corresponding chloroformate ester in the presence of a base.
The base used is selected from a group consisting of alkali metal carbonates like sodium carbonate, potassium carbonate; or a alkali metal hydroxide like sodium hydroxide, potassium hydroxide; or alkali metal bicarbonates like sodium bicarbonate, potassium bicarbonate; or an organic base like triethylamine, tributylamine.
diisopropylethlyamine in a solvent like diisopropylether, tetrahydrofuran, dimethylformamide, dimethoxy ethane, diethyl ketone, propyl acetate, butyl acetate, and propionitrile; and the like. The solvent is selected from diethyl ether, tetrahydrofuran, dioxane, acetone, methyl ethyl ketone, ethyl acetate, acetonitrile, dimethyl formamide, dimethyl acetamide and dimethyl sulfoxide
The above aspects of the present invention are represented in scheme-1 and the process for the preparation of compound of general formula-4 represented in scheme-2 Scheme-1:
P NaBH4
'S^ CH3 Formula-2
~S CH3 Formula-3
solvent, water
acid
u
Formula-4
a) R=Ph
b) R=Et
HO OR
S CH3
Formula-5
a) R=Ph
b) R=Et
solvent
NH3
^
wherein R is a C1.12 all
OH CH3
Formula-3 with phenyl N-hydroxy carbamate, compound of general formula-4a,
"°-N°OPh
H
Formula-4a in toluene in the presence of hydrochloric acid to provide phenyl 1-(benzo[b]thiophen-2-yl)ethyl(hydroxy)carbamate, compound of general formula-5a,
HO OPh
Formula-5a
b) treating compound of formula-5a with ammonia gas in methanol to provide zileuton, compound of formula-1.
The present invention also provides a novel crystalline form of zileuton. The novel crystalline form of the present invention is characterized by its X-ray diffractogram having characteristics peaks 2.81, 5.36, 10.10, 14.89, 15.97, 19.68 and 29.39 degrees at 29 as shovm in figure-1, its Infra red spectrum showing characteristics peaks at 3463.9, 3323.3, 3270, 2988.8, 1657.8, 1470, 1367.6, 1153.4, 828.7 and 729 cm'' as shown in figure-2 and its Differential Scanning Calorimetry showing endothermic peak at 159.42°C as shown in figure-3 and having rod shaped morphology as seen through microscope as shown in figure-4.
XRD analysis of Zileuton was carried out using SIEMENS/D-5000 X-Ray diffractometer using Cu, Ka radiation of wavelength 1.54 A° and continuous scan speed of 0.0457min. FI-IR spectrum of Zileuton was recorded on Thermo model Nicolet-380 as KBr pellet. The thermal analysis of Zileuton was carried out on Waters DSC Q-10 model differential scanning calorimeter.
The process described in the present invention was demonstrated in examples illustrated below. These examples are provided as illustration only and therefore should not be construed as limitation of the scope of the invention.
Examples:
Example-1: Preparation of l-(benzo[b]thiopheii-2-yl) ethanol (formula-3).
2-acetyl benzothiophene (formula-2) (50grams) was taken in methanol (200ml) and stirred for 15 min. The reaction mixture was cooled to 0-5°C and sodium borohydride (6.5grams) was added to it and stirred for 45 min at 0-5°C. Water (500ml) was added to the reaction mixture and stirred for 15 min. The temperature of the reaction mixture is raised to 25-3 0°C and extracted with dichloromethane. The solvent was distilled off under reduced pressure and n-heptane (25ml) was added to reaction mixture. It was stirred for 15 minutes and then the solvent was distilled off under the reduced pressure. The reaction mixture was cooled to 25-30°C, n-heptane (150ml) was added and further cooled to 0-5°C. It was stirred for one hour; the solid obtained was filtered, washed with chilled n-heptane (25ml) and dried to obtain the title compound. Yield: 46 grams.
Example-2: Preparation of l-(benzo[b]tliiophen-2-yI) ethanol (formula-3).
2-acetyl benzothiophene (fonnula-2) (50grams) was taken in methanol (200ml) and stirred for 15 min. The reaction mixture was cooled to 0-5°C and sodium borohydride (6.5grams) was added to it and stirred for 45 min at 0-5°C. Water (500ml) was added to the reaction mixture and stirred for 15 min. The temperature of the reaction mixture is raised to 25-30°C and extracted with dichloromethane. The solvent was distilled off under reduced pressure and water (500ml) was added to reaction mixture. The pH of the reaction mixture was adjusted to 7.0 -7.5 with 20% hydrochloric acid and stirred for one and half hours at 25-30°C. The solid obtained was filtered, washed with chilled water (100ml) and dried to obtain the title compound. Yield: 48 grams.
Example-3: Preparation of phenyl hydroxycarbamate (formula-4a).
Hydroxylamine hydrochloride (44.4 grams), potassium carbonate (97.2 grams) was taken in diisopropylether (500 ml) and water (100 ml) was added to the reaction mixture. The reaction mixture was cooled to 5-10°C and a mixture of phenylchloro formate (100 grams) taken in diisopropyl ether (500 ml) was added to it. The temperature was raised to 25-3 0°C and stirred for 5 hours. The organic and aqueous layers were separated and the solvent was distilled off from the organic layer under reduced pressure. n-Heptane (50 ml) was added to obtained material, stirred for 5 minutes and then distilled off under the reduced pressure. The reaction mixture was cooled to 25-30°C and a mixture of n-heptane (500 ml) and diisopropylether (100 ml) was added to it. The solid obtained was filtered, and v^ashed with n-heptane (100 ml) and dried to get the title compound. Yield: 64 grams.
Example-4: Preparation of phenyl l-(benzo[b]thiophen-2-yl)ethyI(hydroxy) carbamate (formuIa-Sa).
To l-(benzo[b]thiophen-2-yl) ethanol (10 grams) (formula-3) taken in toluene (100 ml) added a mixture of phenyl hydroxycarbamate (14.6 grams), water (11 ml) and hydrochloric acid (17 ml). Heated the reaction mixture to 50-55°C and stirred for 5 hours. The reaction mixture was cooled to 10-15°C. The solid obtained was filtered and washed with toluene (10 ml). The wet material was taken in toluene (85 ml) and ethyl acetate (15 ml), heated to 65-70°C and stirred for 30 minutes. Cooled the reaction mixture to 10-15°C and stirred for 1 hour. The precipitated solid was filtered, washed with toluene (10 ml) and dried to get the title compound. Yield: 12 grams.
Example-5: Preparation of Zileuton (formula-1).
Dissolved phenyl l-(benzo[b]thiophen-2-yl)ethyl(hydroxy)carbamate (5 grams) (formula-5a) in methanol (100 ml). The mixture was cooled to 5-10°C and ammonia gas was passed into the reaction mixture for 24 hours. The temperature of the reaction mixture was raised to 25-30°C. The solvent was distilled off under reduced pressure at 50°C. Toluene (5 ml) was added to obtain material and then distilled off under the
reduced pressure. The reaction mixture was cooled to 25-30°C and toluene (25 ml) was added. Stirred for 45 minutes and filtered the precipitated solid. Washed with toluene (5 ml) and dried to obtain the title compound. Yield: 2.5 grams.
Example-6: Ethyl l-(benzo[b]thiophen-2-yl)ethyl(hydroxy) carbamate (formula-5b).
Hydroxylamine hydrochloride (2 grams), potassium carbonate (4 grams) was taken in and water (10 ml) was added to the reaction mixture. The reaction mixture was cooled to 5-15°C and ethyl chloroformate (2.5 ml) was added to it. The temperature was raised to 5-15°C and stirred for 5 houi's. The pH of the reaction mixture was adjusted to 3 with 6N hydrochloric acid and extracted with tetrahydrofuran. The solvent was distilled off imder reduced pressure. Then reaction mixture was extracted with dichloromethane. The dichloromethane layer was dried over anhydrous sodium sulfate and then distilled off under the reduced pressure to obtain a residue. To the residue added water (2 ml) and hydrochloric acid and (3 ml) and l-(benzo[b]thiophen-2-yl) ethanol (formula-3) (2 grams taken in 15 ml of toluene). The reaction mixture was heated to 50-55°C and stirred for 5 hours. And then it was cooled to 20-25°C, the organic and aqueous layers were separated. The organic layer was dried over anhydrous sodium sulfate and distilled off under reduced pressure to obtain the title compound as oil. Yield: 2 grams
ExampIe-7: Preparation of l-(benzo[b]thiophen-2-yl) ethanone oxime (formula-7).
To a solution of 2-acetyl benzothiophene (10 grams) taken in methanol (100 ml) added hydroxyl amine hydrochloride (6 grams) and pyridine (100 ml).The reaction mixture was stirred for 1 hour at 25-30°C. The reaction was quenched with water (500 ml) and extracted with dichloromethane (100 ml). The organic layer was washed with water (200 ml). The solvent from the organic layer was distilled off under the reduced pressure, n-heptane (20 ml) was added to the reaction mixture and then distilled off under reduced pressure, n-heptane (50 ml)was added to the reaction mixture, cooled to 0-5°C and stirred 30 minutes. Filtered the precipitated solid, washed with n-heptane (20 ml) and dried it to obtain title compound. Yield: 9.8 grams.
Example-8: Preparation of N-(l-(benzo[b]thiophen-2-yI)ethyl)hydroxylamine (formuIa-8).
l-(benzo[b]thiophen-2-yl)ethanone oxime (formula-7) (3.5 grams) was taken in ethanol (25 ml), cooled to 0-5°C and borane-pyridine (3.4 grams) was added to it very slowly. Hydrochloric acid (20%) in ethanol was added to the reaction mixture and the temperature was raised to 20-25°C stirred for 3 hours. The reaction mixture was cooled to 0-5°C and aqueous sodium bicarbonate solution (20 ml) was added slowly to the reaction mixture. The reaction mixture was extracted with dichloromethane (50 ml). The dichloromethane layer was washed with water and distilled off under reduced pressure. Diisopropyl ether (17.5 ml) was added to the reaction mixture, cooled to 0-5°C and stirred for 30 minutes. Filtered the obtain solid, washed with diisopropyl ether (7 ml) and dried to obtain title compound. Yield: 2.6 grams.
Example-9: Preparation of Zileuton,,
N-(l-(benzo[b]thiophen-2-yl)ethyl)hydroxylamine (Igram) (formula-8) was mixed with urea (0.6 grams) and then heated to 135-140°C for two hours. The reaction mixture was cooled to 25-30°C, and water (2 ml) and toluene (2 ml) was added to it. Stirred the reaction mixture for 30 minutes. Filtered the obtain precipitate, washed with toluene (2 ml) and dried to obtain title compound. Yield: 0.2 grams.
Example-10: Preparation of Zileuton.
l-(benzo[b]thiophen-2-yl)etha][iol (formula-3) (1 gram) was mixed with N-hydroxyurea (1 gram), anhydrous zinc chloride (0.7 grams) and then heated to 135-140°C for one hour. The reaction mixture was cooled to 25-30°C, and water (2 ml) and toluene (2 ml) was added to it .The reaction mixture was stirred for 30 minutes. Filtered the obtain precipitate, washed with toluene (2 ml) and dried to obtain title compound. Yield: 0.6 grams.
We Claim:
1) An improved process for the preparation of zileuton compound of formula-1, which comprises of the following steps; a) Treating l-(benzo[b]thiophen-2-yl)ethanone compound of formula-2, with
1
wherein R is a Ci.n alkyl, C3.7 cycloalkyl, aryl or aryl-Ci-ealkyl,
c) treating compound of formula- 5 with ammonia to provide zileuton, compound of formula-1.
2) An improved process for the preparation of zileuton, compound of formula-1, which comprises of the following steps, a) reacting the compound of formula-3,
wherein R is a CM2 alkyl, C3.7 cycloalkyl, aryl or aryl-Ci-6 alkyl, b) treating compound of formula-5 with ammonia source to provide zileuton, compound of formula-1.
3) A process according to claim 1 and 2, wherein
i) In the condensation of l-(benzo[b]thiophen-2-yl)ethanol, compound of formula-3, with N-hydroxy carbamate, compound of general formula-4, the solvent used is selected form a group of non polar aprotic solvents which includes but is not limited to benzene, toluene, xylene, tetrahydofuran, 2-methyltetrahydrofuran, preferably toluene; and ii) In the condensation of l-(benzo[b]thiophen-2-yl)ethanol, compound of formula-3, with N-hydroxy carbamate, compound of general formula-4 the acid used is selected from either an inorganic acid or organic acid. The inorganic acid is selected from a group consisting of but not limited to hydrochloric acid,
hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid and the like or lewis acids like aluminium chloride, aluminium bromide, ferric chloride, boron trifluoride, boron trichloride, stannous chloride, titanium tetrachloride and the like. The organic acid is selected from a group consisting of but not limited to acetic acid, trifluoroacetic acid, ethanoic acid, propionic acid, paratoluene sulfonic acid and the like; iii) The ammonia source used in the aminolysis of compound of general formula-5, is selected form a group includes ammonia gas, ammonium hydroxide, ammonium acetate, ammonium chloride, iimmonium carbonate, and the like, and the suitable solvent that can be used includes, without limitation, aromatic hydrocarbon solvents like toluene, xylene; halogenated solvents such as dichloromethane, chloroform, 1,2-dichloroethane and the like; alcoholic solvent like methanol, ethanol, isopropanol, n-propanol, n-butanol, isobutanol; keto solvents like acetone, methyl ethyl ketone, diethyl ketone; ester solvents like ethyl acetate, propyl acetate and acetonitile.
4) A process for preparing zileuton, compound of formula-1, which comprises of
treating compound of formula-5
wherein R is methyl or phenyl,
with ammonia in an alcohol solvent to provide zileuton.
5) An improved process for the prepjiration of zileuton, compound of formula-1, which
comprises of the following steps,
a) reacting the compound of fonnula-3,
with phenyl N-hydroxy carbamate, compoxmd of general formula-4a,
in toluene in the presence of hydrochloric acid to provide l-(benzo[b]thiophen-2-yl) ethyl(hydroxy)carbamate, compound of general formula-5a,
b) treating compound of formuIa-Sa with ammonia gas to provide zileuton, compound of formula-1.
6) Ethyl l-(benzo[b]thiophen-2-yl)ethyl(hydroxy) carbamate, compound of formula-5b.
wherein R is a Cun alkyl, C3.7 cycloalkyl, aryl or aryl-Ci-e alkyl, with a proviso that R is not a phenyl group.
8) An improved process for the preparation of zileuton, compound of formula-1, which comprises of reacting the compound l-(benzo[b]thiophen-2-yl)ethanol, compound of formula-3, with N-hydroxyurea in the presence of zinc chloride in presence/absence
of a suitable solvent like hydrocarbon solvents or chlorosolvents, to provide zileuton compound of formula-1.
9) An improved process for the preparation of zileuton, compound of formula-1, which
comprises of the following steps,
a) Reacting l-(benzo[b]thiophen-2-yl)ethanone compound of formula-2 with
hydroxylamine to provide l-(benzo[b]thiophen-2-yl)ethanone oxime, compound
offormula-7,
b) reducing the compound of formula-7 using borane-pyridine complex to provide
N-(l -(benzo[b]thiophen-2-yl)ethyl)hydroxylamine compound of formula-8,
c) reacting the compound of forraula-S, with urea in presence/absence of a suitable
solvent to provide zileuton, compound of formula-1.
10) Crystalline Zileuton characterized by any one of the following
a) by its X-ray diffractograrn having characteristics peaks 2.81, 5.36, 10.10,
14.89,15.97,19.68 and 29.39 degrees at 26 as shown in figure-1;
b) by its Infra red spectrum showing characteristics peaks at 3463.9, 3323.3,
3270, 2988.8, 1657.8, 1470, 1367.6, 1153.4, 828.7 and 729 cm"' as shown in
figure-2;
c) by its Differential Scanning Calorimetry showing endothermic peak at
159.42°C as shown in figure-3;
d) having rod shaped morphology as seen through microscope as shown in
figure-4.
| # | Name | Date |
|---|---|---|
| 1 | 2307-CHE-2009-REQUEST FOR CERTIFIED COPY [30-05-2018(online)].pdf | 2018-05-30 |
| 1 | abs 2307-che-2009 abstract 23-09-2009.jpg | 2009-09-23 |
| 2 | 2307-che-2009 form-2 23-09-2009.pdf | 2009-09-23 |
| 2 | 2307-CHE-2009-IntimationOfGrant28-02-2018.pdf | 2018-02-28 |
| 3 | 2307-CHE-2009-PatentCertificate28-02-2018.pdf | 2018-02-28 |
| 3 | 2307-che-2009 form-1 23-09-2009.pdf | 2009-09-23 |
| 4 | Abstract_Granted 293566_28-02-2018.pdf | 2018-02-28 |
| 4 | 2307-che-2009 drawings 23-09-2009.pdf | 2009-09-23 |
| 5 | Claims_Granted 293566_28-02-2018.pdf | 2018-02-28 |
| 5 | 2307-che-2009 description (complete) 23-09-2009.pdf | 2009-09-23 |
| 6 | Description_Granted 293566_28-02-2018.pdf | 2018-02-28 |
| 6 | 2307-che-2009 correspondence others 23-09-2009.pdf | 2009-09-23 |
| 7 | Drawings_Granted 293566_28-02-2018.pdf | 2018-02-28 |
| 7 | 2307-che-2009 claims 23-09-2009.pdf | 2009-09-23 |
| 8 | Correspondence [30-06-2017(online)].pdf | 2017-06-30 |
| 8 | 2307-che-2009 abstract 23-09-2009.pdf | 2009-09-23 |
| 9 | 2307-che-2009 correspondence others 28-04-2010.pdf | 2010-04-28 |
| 9 | Description(Complete) [30-06-2017(online)].pdf | 2017-06-30 |
| 10 | 2307-che-2009 form-18 28-04-2010.pdf | 2010-04-28 |
| 10 | Description(Complete) [30-06-2017(online)].pdf_559.pdf | 2017-06-30 |
| 11 | 2307-che-2009 form-3 18-10-2010.pdf | 2010-10-18 |
| 11 | Examination Report Reply Recieved [30-06-2017(online)].pdf | 2017-06-30 |
| 12 | 2307-CHE-2009 FORM-3 20-03-2014.pdf | 2014-03-20 |
| 12 | Other Document [30-06-2017(online)].pdf | 2017-06-30 |
| 13 | 2307-CHE-2009-FER.pdf | 2016-12-30 |
| 14 | 2307-CHE-2009 FORM-3 20-03-2014.pdf | 2014-03-20 |
| 14 | Other Document [30-06-2017(online)].pdf | 2017-06-30 |
| 15 | 2307-che-2009 form-3 18-10-2010.pdf | 2010-10-18 |
| 15 | Examination Report Reply Recieved [30-06-2017(online)].pdf | 2017-06-30 |
| 16 | 2307-che-2009 form-18 28-04-2010.pdf | 2010-04-28 |
| 16 | Description(Complete) [30-06-2017(online)].pdf_559.pdf | 2017-06-30 |
| 17 | Description(Complete) [30-06-2017(online)].pdf | 2017-06-30 |
| 17 | 2307-che-2009 correspondence others 28-04-2010.pdf | 2010-04-28 |
| 18 | 2307-che-2009 abstract 23-09-2009.pdf | 2009-09-23 |
| 18 | Correspondence [30-06-2017(online)].pdf | 2017-06-30 |
| 19 | Drawings_Granted 293566_28-02-2018.pdf | 2018-02-28 |
| 19 | 2307-che-2009 claims 23-09-2009.pdf | 2009-09-23 |
| 20 | Description_Granted 293566_28-02-2018.pdf | 2018-02-28 |
| 20 | 2307-che-2009 correspondence others 23-09-2009.pdf | 2009-09-23 |
| 21 | Claims_Granted 293566_28-02-2018.pdf | 2018-02-28 |
| 21 | 2307-che-2009 description (complete) 23-09-2009.pdf | 2009-09-23 |
| 22 | Abstract_Granted 293566_28-02-2018.pdf | 2018-02-28 |
| 22 | 2307-che-2009 drawings 23-09-2009.pdf | 2009-09-23 |
| 23 | 2307-CHE-2009-PatentCertificate28-02-2018.pdf | 2018-02-28 |
| 23 | 2307-che-2009 form-1 23-09-2009.pdf | 2009-09-23 |
| 24 | 2307-CHE-2009-IntimationOfGrant28-02-2018.pdf | 2018-02-28 |
| 24 | 2307-che-2009 form-2 23-09-2009.pdf | 2009-09-23 |
| 25 | 2307-CHE-2009-REQUEST FOR CERTIFIED COPY [30-05-2018(online)].pdf | 2018-05-30 |
| 25 | abs 2307-che-2009 abstract 23-09-2009.jpg | 2009-09-23 |
| 1 | searchstrategy2307_13-12-2016.pdf |